MedTrace Logo

Pharmacokinetic Interactions of Bisoprolol and Rosuvastatin

NCT01925300 · Status: WITHDRAWN · Phase: PHASE1 · Type: INTERVENTIONAL

Last updated 2016-12-29

No results posted yet for this study

Summary

This study is designated to evaluate the pharmacokinetic interactions of bisoprolol and rosuvastatin in healthy male volunteers.

Conditions

  • Healthy

Interventions

DRUG

Concor 5mg(Bisoprolol hemifumarate 5mg) 2Tab

DRUG

Crestor 20mg(Rosuvastatin calcium 20.80mg) 1Tab

DRUG

Concor 5mg 2T and Crestor 20 mg 1Tab

Sponsors & Collaborators

  • HK inno.N Corporation

    lead INDUSTRY

Principal Investigators

  • Jae-wook Ko, phD · Samsung Medical Conter

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
20 Years
Max Age
55 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-07-31
Primary Completion
2013-09-30
Completion
2013-09-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01925300 on ClinicalTrials.gov